Tango Therapeutics
(NASDAQ) TNGX
Tango Therapeutics Financials at a Glance
Market Cap
$4.64B
Revenue (TTM)
$56.99M
Net Income (TTM)
-$107.23M
EPS (TTM)
-$0.82
P/E Ratio
-34.76
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$28.44
Volume
5,387,184.623
Open
$28.01
Price
$28.44
Volume
5,387,184.623
Open
$28.01
Previous Close
$28.39
Daily Range
$28.01 - $29.09
52-Week Range
$4.60 - $34.39
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$28.44
Volume
5,387,184.623
Open
$28.01
Previous Close
$28.39
Daily Range
$28.01 - $29.09
52-Week Range
$4.60 - $34.39
Estimated Earnings Date
Aug 5, 2026
TNGX News
TNGX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tango Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
137
CEO
Malte Peters, MD
Website
www.tangotx.comHeadquarters
Boston, MA 02142, US
TNGX Financials
Key Financial Metrics (TTM)
Gross Margin
97.25%
Operating Margin
-206.22%
Net Income Margin
-188.15%
Return on Equity
-41.54%
Return on Capital
-29.31%
Return on Assets
-24.61%
Earnings Yield
-2.88%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.64B
Shares Outstanding
162.81M
Volume
5.39M
Avg. Volume
3.79M
Financials (TTM)
Gross Profit
$55.43M
Operating Income
-$117.53M
EBITDA
-$105.14M
Operating Cash Flow
-$141.55M
Capital Expenditure
-$995.00K
Free Cash Flow
-$142.54M
Cash & ST Invst.
$379.84M
Total Debt
$32.79M
Tango Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
-$463.00K
-108.6%
Gross Margin
0.00%
N/A
Market Cap
$4.64B
N/A
Market Cap/Employee
$29.94M
N/A
Employees
155
N/A
Net Income
-$45.51M
-14.1%
EBITDA
-$45.05M
-14.9%
Quarterly Fundamentals
Total Cash
$379.84M
+75.3%
Total Debt
$32.79M
-11.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$29.96M
-12.2%
Short Term Debt
$2.83M
+0.3%
Return on Assets
-24.61%
N/A
Return on Invested Capital
-27.89%
N/A
Free Cash Flow
-$44.36M
-6.3%
Operating Cash Flow
-$44.36M
-6.4%